Your session is about to expire
← Back to Search
Electronic Pillbox Monitoring System for Medication Adherence
Phase 1 & 2
Waitlist Available
Led By Connie M Trinacty, PhD
Research Sponsored by Harvard Pilgrim Health Care
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights
Summary
The objective of this pilot study is to explore barriers to medication adherence among HPHC members with CKD, particularly those not yet on dialysis, and to assess the feasibility and acceptability of a wireless, internet-based MedMinder system intervention among HPHC enrollees with CKD and their care partners. The investigators hypothesize that the intervention will improve medication use and adherence among patient members with CKD on complex medication treatment, and improve informal caregivers' ability to provide support for improved medication use among patient members.
Eligible Conditions
- Medication Adherence
- Chronic Kidney Disease
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
medication adherence
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Electronic Pillbox Monitoring SystemExperimental Treatment1 Intervention
Usual care plus receive use of the wireless electronic pillbox and medication monitoring system
Group II: Usual CareActive Control1 Intervention
Usual care patients will have outpatient care and monitoring procedures, as determined by them and their health care providers.
Find a Location
Who is running the clinical trial?
Harvard Pilgrim Health CareLead Sponsor
59 Previous Clinical Trials
24,984,638 Total Patients Enrolled
Connie M Trinacty, PhDPrincipal InvestigatorHarvard Medical School and Harvard Pilgrim Health Care Institute
Ashley J Beard, PhDStudy DirectorUniversity of Michigan
Share this study with friends
Copy Link
Messenger